Global Pediatric Interventional Cardiology Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387400
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The global market for Pediatric Interventional Cardiology is poised to reach $1.78 billion by the end of 2020 growing at a CAGR of 7.6%. Interventional Cardiology is a specialty within cardiology where cardiovascular procedures are performed with the use of catheters. The procedures include angioplasty, stenting and are performed by using guiding tools through the bodys blood vessels. The main advantages if using the interventional cardiology is the avoidance of scars and pain, and long post-operative recovery. The various procedures performed by specialists in interventional cardiology include Angioplasty, Valvuloplasty, Congenital heart defection correction, percutaneous valve replacement and coronary thrombectomy.

Currently, North America is the largest market in the world followed by Europe. APAC is the fastest growing segment. The global pediatric interventional cardiology market can be segmented on the basis of Product (Closure devices, Transcatheter heart valves, atherectomy devices, Catheters, guidewires, balloons and stents), Imaging technique (IVUS, OCT, NIRS) and Geography (North America, Europe, APAC & RoW).


Rapid technological advances, increasing awareness among the population, increased preference of minimally invasive surgical procedures, increasing Government support towards pediatric interventional cardiology market and emerging economies presenting significant growth opportunities are the major factors contributing to the growth of the market.


Different regulatory policies delaying the product launches, expensive instruments, complex nature of pediatric clinical trials and unfavorable market conditions for new players are the major challenges faced by the market.

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Pediatric Interventional Cardiology Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Pediatric Interventional Cardiology market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Research Methodology
2. Key Findings
3. Executive Summary
4. Market Dynamics
4.1 Market Segmentation
4.2 Market Drivers
4.2.1 Increase in the number of chronic & infectious diseases
4.2.2 Rapid aging population
4.2.3 Technological advances
4.2.4 General awareness about healthcare among the population
4.2.5 Increase in the adoption of Home based healthcare technologies
4.2.6 Increase in the investments on R&D to develop novel products
4.2.7 Low penetration of POC diagnostics in the emerging economies
4.2.8 Rapid economic development in the emerging nations
4.3 Market Restraints
4.3.1 Reluctance from the medical indsutry towards changing the existing norms
4.3.2 Product recalls
4.3.3 Lack of co-ordination among healthcare organizations
4.3.4 Stringent regulatory framework
4.3.5 Unfavorable reimbursement scenario
5. Global Market Segmentation
5.1 By Product
5.1.1 Infectious Diseases
5.1.2 Glucose Monitoring
5.1.3 Cardiac Markers
5.1.4 Hematology
5.1.5 Oncology Markers
5.1.6 Coagulation
5.1.7 OTC Diagnostic Tests
5.1.8 Urinalysis
5.1.9 Drugs of abuse
5.1.10 Fertility Testing
5.1.11 Blood Gas Testing
5.1.12 Others
5.2 By End Users
5.2.1 Hospitals
5.2.2 Laboratories
5.2.3 Home Healthcare
5.2.4 Others
5.3 By Mode of Delivery
5.3.1 OTC
5.3.2 Prescription
5.4 By Geography
5.4.1 North America US Canada Mexico
5.4.2 Europe UK Germany France Spain Italy Rest of Europe
5.4.3 Asia Pacific China Japan India South Korea Rest of Asia Pacific
5.4.4 Rest of the World
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Abbott Laboratories
7.2 Agendia
7.3 Agilent/Dako
7.4 Alere Inc
7.5 Arkray Inc
7.6 Bayer AG
7.7 Becton Dickinson & Company
7.8 Biomerieux
7.9 BioRad Laboratories
7.10 Cepheid
7.11 Danaher Corporation
7.12 Foundation Medicine
7.13 Genomic Health
7.14 Grifols
7.15 Hologic
7.16 Illumina
7.17 Johnson & Johnsons
7.18 Myriad Genetics
7.19 QIagen
7.20 Roche Diagnostics
7.21 Siemens
7.22 Sysmex
8. Appendix
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown